4.8 Article

Low glycaemic diets alter lipid metabolism to influence tumour growth

期刊

NATURE
卷 599, 期 7884, 页码 302-307

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41586-021-04049-2

关键词

-

资金

  1. Damon Runyon Cancer Research Foundation [DRG-2299-17, DRG-2241-15]
  2. NIH Pathway to Independence Award [K99CA234221]
  3. NIH [T32GM007287, U01CA210171, P50CA127003, R35CA242379, R01CA168653, R01CA201276, P30CA14051, UM1 CA186107, U01 CA176726, P01 CA87969, U01 CA167552, R03 CA223619]
  4. Lustgarten Foundation
  5. Dana-Farber Cancer Institute Hale Family Center for Pancreatic Cancer Research
  6. Stand Up To Cancer
  7. Pancreatic Cancer Action Network
  8. Noble Effort Fund
  9. Wexler Family Fund
  10. Bob Parsons Fund
  11. Emerald Foundation
  12. Howard Hughes Medical Institute
  13. MIT Center for Precision Cancer Medicine
  14. Ludwig Center at MIT
  15. Promises for Purple

向作者/读者索取更多资源

Dietary interventions can impact tumour growth by altering metabolite levels in the tumour microenvironment. While caloric restriction and a ketogenic diet have different effects on tumour growth inhibition, with caloric restriction affecting lipid levels and fatty acid balance, the ketogenic diet influences tumour fatty acid desaturation and composition.
Dietary interventions can change metabolite levels in the tumour microenvironment, which might then affect cancer cell metabolism to alter tumour growth(1-5). Although caloric restriction (CR) and a ketogenic diet (KD) are often thought to limit tumour progression by lowering blood glucose and insulin levels(6-8), we found that only CR inhibits the growth of select tumour allografts in mice, suggesting that other mechanisms contribute to tumour growth inhibition. A change in nutrient availability observed with CR, but not with KD, is lower lipid levels in the plasma and tumours. Upregulation of stearoyl-CoA desaturase (SCD), which synthesises monounsaturated fatty acids, is required for cancer cells to proliferate in a lipid-depleted environment, and CR also impairs tumour SCD activity to cause an imbalance between unsaturated and saturated fatty acids to slow tumour growth. Enforcing cancer cell SCD expression or raising circulating lipid levels through a higher-fat CR diet confers resistance to the effects of CR. By contrast, although KD also impairs tumour SCD activity, KD-driven increases in lipid availability maintain the unsaturated to saturated fatty acid ratios in tumours, and changing the KD fat composition to increase tumour saturated fatty acid levels cooperates with decreased tumour SCD activity to slow tumour growth. These data suggest that diet-induced mismatches between tumour fatty acid desaturation activity and the availability of specific fatty acid species determine whether low glycaemic diets impair tumour growth. Lien et al. show that low glycemic diets can reduce tumour growth by deregulating lipid metabolism.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据